(1)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(2)
In addition to the samples required in accordance with the table in point (5), in 2017 each Member State shall take and analyse five samples of infant formulae and five samples of follow-on formulae.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(3)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(4)
Member States using multi-residue methods may use qualitative screening methods on up to 15 % of the samples to be taken and analysed in accordance with the table in point (5). Where a Member State uses qualitative screening methods, it shall analyse the remaining number of samples by quantitative multi-residue methods.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(5)
Minimum number of samples per Member State per commodity:
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .